Global Anti-Aging Drugs Market Definition
Anti-aging research exclusively means the early detection, slowing, preventing, or reversing of the aging process with the use of anti-aging drugs that aid in the prevention, and treatment of age-related diseases. There is a wide array of strategies and therapies currently available that acclaims the slowing or reversing of aging in humans, with the future of the anti-aging drugs market looking very promising in the upcoming years. Broadly, the global population is keener to feel younger and look in some way or the other in spite of the growing age.
Global Anti-Aging Drugs Market: Key Insights
|
Base Year |
2022 |
|
Forecast Year |
2023-2033 |
|
CAGR |
~7% |
|
Base Year Market Size (2022) |
~ USD 49 Billion |
|
Forecast Year Market Size (2033) |
~ USD 95 Billion |
|
Regional Scope |
|
Global Anti-Aging Drugs Market Size, Forecast, and Trend Highlights Over 2023 - 2033
The global anti-aging drugs market is estimated to garner a revenue of ~USD 95 billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033. Further, the market generated a revenue of ~USD 49 billion in the year 2022. The growth of the market can be attributed primarily to the rising aging population around the world with the rising hope for extending the healthy lifespan of humans having youthful characteristics. According to the World Health Organization, globally, the percentage of people over 60 years of age will nearly double from 12% to 22% between 2015 and 2050.
Get more information on this report:Request Sample PDF
In the prevention and treatment of age-related disorders and diseases, anti-aging drugs combine advanced biotechnology and clinical prevention medicines. Anti-aging drugs are mostly used by the baby boomer generation, as well as by consumers who care more about their health and appearance. Using these drugs, the body is able to reverse the effects of aging. The aging process is also being delayed through a wide variety of medical technologies.
Global Anti-Aging Drugs Market: Growth Drivers and Challenges
Growth Drivers
-
Growing Prevalence of Photoaging Among People - premature aging of the skin is caused by sun exposure. Skin damage caused by the sun is referred to by a number of names in dermatology, including photoaging. Certainly, UV exposure causes more visible signs of facial aging. Thus, the rising cases of photoaging are expected to propel the demand for anti-aging drugs during the forecast period. It was observed that, approximately 90% of European and North American adults with skin phototypes I, II, and III show clinically detectable photoaging.
-
An Increasing Number of Dermatologists - for instance, nearly 3,700 dermatologists are presently employed in the United States. Women account for over 85% of dermatologists, while men account for 14%.
-
Rising Personal Disposable Income - according to the Bureau of Economic Analysis, in July 2022 disposable personal income (DPI) increased by USD 37.6 billion (0.2%) in United States.
-
Increasing Level of Chronic Stress Among People- it was observed that globally, approximately 33% of people admitted feeling stressed.
-
Excessive Alcohol Consumption – according to the Centers for Diseases Control and Prevention, nearly 16% of adults are excessive alcohol drinkers, and 6% are reported, as heavy drinkers.
Challenges
-
High Cost of Anti-Aging Drugs - medical research and funding is vital and central for the development of aging-related medications. With huge funds invested in the scientific research and development of these drugs, it is still unaffordable for many.
-
Low Awareness of Anti-Aging Drugs in Low-Income Countries
-
Presence of Alternatives in the Market
The global anti-aging drugs market is segmented and analyzed for demand and supply by type into dermal fillers, botulinum toxin, and others. Among these segments, the dermal fillers segment is anticipated to capture the largest market size in the global anti-aging drugs market owing to the increasing dermal filler injections and higher adoption of derma fillers in treating wrinkles and fine lines. For instance, it was found that in 2018, there were approximately 2.6 million dermal filler injections in America.
Global Anti-Aging Drugs Market Regional Synopsis
The North America anti-aging drugs market, amongst the market in all the other regions, is projected to hold the largest market share by the end of 2033, backed by the increasing number of non-invasive cosmetic treatments, the growing demand for anti-aging products, and the rapid expansion of the personal care industry. For instance, in 2020 nearly 13,280,000 cosmetic minimally invasive surgery procedures were carried out in the United States.
Market Segmentation
Our in-depth analysis of the global anti aging drugs market includes the following segments:
|
By Type |
|
|
By Drug Class |
|
|
By Application |
|
|
By Distribution Channel |
|
Top Featured Companies Dominating the Global Anti-Aging Drugs Market
-
L’Oreal SA
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Merz Pharma GmbH & Co.
- Novartis AG
- BioTime Inc.
- ARK Skincare
- Elysium Health Inc.
- Estee Lauder Inc.
- DermaFix
- Bayer Pharma AG
- La Roche-Posay
